KYTX vs LI · $488.8M cap vs P/E 24, rev $16.06B
Kyverna Therapeutics, Inc. Common Stock (KYTX) versus Li Auto Inc (LI) — a side-by-side from cached financials, not a winner call.
Kyverna Therapeutics, Inc. Common Stock (KYTX) is a biotechnology company listed on NASDAQ.
Li Auto Inc (LI) is a auto manufacturers company listed on US.
KYTX does not have a complete income-statement cache yet.
Latest reported LI revenue for 2025-12-31 was $16.06B. Net income was $162.9M. Revenue was down 18.8% from 2024-12-31 to 2025-12-31. LI currently screens at market cap $26.62B and trailing P/E 24.2.
KYTX currently screens at market cap $488.8M. LI currently screens at market cap $26.62B and trailing P/E 24.2.
Not investment advice. Open the KYTX and LI stock pages for the full models.
Not investment advice.